SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma informs about closure of trading window

28 Dec 2023 Evaluate
Pursuant to the Code of Conduct of the Company and as per the amended provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Bal Pharma has informed that the trading window for dealing with the securities of the Company on the designated employees and their relatives will be closed from 1st January 2024 and up to 48 hours of the declaration of the un-audited financial results of the Company for the quarter and nine months ended 31/12/2023. The date of the Board meeting for declaration of the Un-audited financial results, will be intimated to the exchanges in due course.

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

78.49 0.39 (0.50%)
20-Apr-2026 15:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1666.00
Dr. Reddys Lab 1226.10
Cipla 1228.55
Zydus Lifesciences 932.60
Lupin 2326.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×